Liposomal Melatonin Spray by DaVinci Laboratories — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

0.4 mL Serving Size

75 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Melatonin

3 mg

📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)

This product: 3mg UL 10mg

Other Ingredients

Glycerin Water Sunflower Lecithin Oleic Acid Polyglyceride Citric Acid Xanthan Gum Orange Oil Rosmarinic Acid

Label Claims — Verification

❓ All Other

All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, hold nozzle 1" from mouth, spray twice and swallow, or as directed by your healthcare practitioner. Shake well before each use.

⚠️ Warnings & Precautions

Warning: If pregnant or nursing, consult your healthcare practitioner before taking this product.

Caution: For occasional and/or intermittent use only. Melatonin may cause drowsiness. If you feel groggy, do not drive or operate machinery. Do not take alcohol. Discontinue use 2 weeks prior to surgery.

Keep out of reach of children.

To obtain product information or report a serious adverse event, call 1-800-325-1776.

🧪 Formulation Notes

Vegetarian

Gluten free / Non-GMO Made with soy free ingredients

Additional Information

Store in a cool, dry place. Best if used within 60 days of opening.

Product Details

UPC / SKU 0 26664 23611 1

DSLD Entry Date 2025-02-23

Product Type Non-Nutrient/Non-Botanical

Form Liquid

Brand DaVinci Laboratories

DSLD ID 322179

Data Updated 2026-04-11

Research Evidence

291 Research Sources

55 Avg Quality Score

129 Meta Analysis

93 Systematic Review

51 Rct

11 Clinical Trial

2 Other

2 Regulatory Source

1 Openfda Safety

A Interventions for preventing delirium in hospitalised non-ICU patients

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI

A Melatonin for preoperative and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI Cochrane

A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials

Meta Analysis BMJ open 2022

PubMed DOI

B Pharmacological interventions for prevention of weight gain in people with schizophrenia

Meta Analysis The Cochrane database of systematic reviews 2022

PubMed DOI

B Melatonin for pre- and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Prevention of depression in adults with long-term physical conditions

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

Systematic Review Lancet (London, England) 2022

PubMed DOI

B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis

Meta Analysis BMJ open 2023

PubMed DOI

B Second-generation antidepressants for preventing seasonal affective disorder in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI

B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

View all evidence for Melatonin →